Post marketing study of sofosbuvir and ledipasvir for genotype 1 hepatitis C virus infectio
Not Applicable
- Conditions
- Hepatitis virus infection
- Registration Number
- JPRN-UMIN000023271
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) pregnant woman 2) decompensated cirrhosis 3) severe renal dysfunction (<eGFR30)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response at 12 weekes after the end of therapy
- Secondary Outcome Measures
Name Time Method